Baylor College of Medicine: Gene Signature IDs Drivers of Treatment Resistance in Metastatic Breast Cancer
October 29, 2021
October 29, 2021
HOUSTON, Texas, Oct. 29 (TNSJou) -- The Baylor College of Medicine issued the following news:
A multi-institution team of researchers led by scientists at Baylor College of Medicine has discovered a genetic signature that can identify drivers of poor outcomes in advanced estrogen-receptor positive (ER+) breast cancer, which could one day lead to personalized treatment for patients.
The 24-gene signature detects the presence of mutations and translocations in the ER gene . . .
A multi-institution team of researchers led by scientists at Baylor College of Medicine has discovered a genetic signature that can identify drivers of poor outcomes in advanced estrogen-receptor positive (ER+) breast cancer, which could one day lead to personalized treatment for patients.
The 24-gene signature detects the presence of mutations and translocations in the ER gene . . .